InfuSystem 10-Q Details $5.0M ERP Billing Backlog Behind Q3 Cash Drag
INFU has more than doubled off its 52-week low of $7.29.
Summary
InfuSystem's Q3 10-Q repeats the November 5 results but newly quantifies about $5.0 million of receivables stuck behind ERP invoicing problems, of which roughly $1.3 million has since been collected.
Key Events · Earnings and Guidance · INFU
-
Q3 Results Already Released
Revenue of $37.6 million rose 3.0% from $36.5 million, and net income of $3.2 million, or $0.15 diluted, compared with $2.3 million, or $0.11, a year earlier.
-
ERP Billing Glitch Ties Up Cash
About $5.0 million of the $29.6 million in accounts receivable at September 30 was attributed to delayed invoicing and collection from the new ERP system; roughly $1.3 million of that excess had been collected through the filing date.
-
Operating Cash Flow Still Solid
Nine-month operating cash flow was $18.1 million versus $17.3 million a year earlier, and cash rose to $9.1 million from $3.2 million at December 31, 2025.
-
Buyback and Liquidity Intact
The company repurchased 50,439 shares for about $0.6 million under the new $20.0 million program, and had $55.0 million available on its revolver with all debt covenants met.
Analysis · INFU · Industrial Applications And Services
The quarter itself was already public: revenue of $37.6 million, up 3.0%, and net income of $3.2 million, or $0.15 diluted, were released November 5. What is new in the full 10-Q is the size of the ERP problem. Management estimates roughly $5.0 million of the $29.6 million receivables balance at September 30 stemmed from invoicing and collection delays tied to the new ERP system, and only about $1.3 million of that excess had been collected by the filing date. That matters because the company is otherwise generating solid cash — $18.1 million from operations over nine months — and carries $9.1 million of cash plus $55.0 million of undrawn revolver capacity. The risk is execution, not solvency: if the billing cleanup slips, working capital stays tied up and the buyback under the new $20.0 million authorization slows.
How filings like this one have moved
In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, INFU was trading at $14.68 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $292.4M. The 52-week trading range was $7.29 to $14.85. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.